Comparing <scp>SGLT2i</scp> and Other Oral Antidiabetic Drugs as Dual Therapy Add‐On to Metformin in Type 2 Diabetes: A Systematic Review and Meta‐Analysis
Compared with other ODTs, SGLT-2i plus metformin exhibited overall comparable efficacy and safety, with a lower risk of hypoglycaemia and greater weight reduction at Week 52.
Authors
- Yuhang Ma (ORCID: https://orcid.org/0000-0002-5931-5846)
- YONGDE PENG
- Yi Lin
- Xiaoying Ding
Institutions
- Shanghai Jiao Tong University (CN)
Publication Details
- Journal
- Endocrinology Diabetes & Metabolism
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1002/edm2.70176
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca